Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial
Combining HAIP chemotherapy with floxuridine and systemic gem-cis in patients with unresectable liver-confined iCCA had a 1- and 3-year OS superior to gem-cis alone in historical cohorts.
Authors
- Bianca Mostert (ORCID: https://orcid.org/0000-0001-5193-0820)
- Rutger‐Jan Swijnenburg (ORCID: https://orcid.org/0000-0002-3980-4634)
- Bas Groot Koerkamp (ORCID: https://orcid.org/0000-0003-1917-6973)
- Wills F. Filipe
- Heinz‐Josef Klümpen (ORCID: https://orcid.org/0000-0002-7290-1823)
- Stijn Franssen (ORCID: https://orcid.org/0000-0002-3098-9054)
- Florian E. Buisman (ORCID: https://orcid.org/0000-0002-2516-4058)
- Marjolein Y.V. Homs (ORCID: https://orcid.org/0000-0001-9828-2541)
- Jeroen Hagendoorn (ORCID: https://orcid.org/0000-0001-8737-3923)
- Nadia Haj Mohammad (ORCID: https://orcid.org/0000-0002-4688-2921)
- Merve Rousian
- B. Ten Haaft (ORCID: https://orcid.org/0009-0000-1515-7447)
- Michael Doukas
Institutions
- University of Applied Sciences Utrecht (NL)
- Utrecht University (NL)
- University Medical Center Utrecht (NL)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1200/jco-25-00923
- Citations
- 4
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 5.29